Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi CT³) is a research infrastructure focused on targeted therapy technologies. It aims to accelerate the path from basic science to product by holistically supporting the full continuum from early-stage research to clinical application.

Vision

“To be a leading center where knowledge in targeted therapy technologies is advanced and innovations and technologies are pioneered globally.”

To be a source of knowledge in targeted therapy technologies; and, as a global pioneer of discoveries and technologies, to lead the development of a globally competitive, sustainable, and high value-added ecosystem—driven by Türkiye’s leadership in life sciences and health technologies.

Mission

“To generate, develop, and disseminate knowledge and technologies in targeted therapy to improve quality of life.”

To generate scientific and technological value in targeted therapy technologies; to transform these outputs into economic value; and to contribute to improving society’s quality of life. In this direction, we increase impact by supporting translational studies throughout the process—from research ideas to readiness for clinical application.

The Boğaziçi CT³ approach

From research to application: Holistically supports the continuum from early-stage research to clinical application.
From basic science to product: Focuses on accelerating the journey toward productization.
Ecosystem and collaborations: Aims to foster a sustainable, high value-added targeted therapy technologies ecosystem through academia–startup–industry collaborations.